1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By
Drug Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and
Oncolytic Viral Therapy, others)
5.2.2.
By
Service Type (Target Identification and Validation, Lead Screening and
Characterization, Cell-based Assays)
5.2.3.
By
Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Others)
5.2.4.
By Region
5.2.5.
By Company (2022)
5.3.
Market Map
6. Asia Pacific Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Drug Type
6.2.2.
By Service Type
6.2.3.
By Cancer
Type
6.2.4.
By Country
6.3.
Asia Pacific: Country Analysis
6.3.1.
China Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug
Type
6.3.1.2.2.
By
Service Type
6.3.1.2.3.
By Cancer
Type
6.3.2.
India Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug
Type
6.3.2.2.2.
By
Service Type
6.3.2.2.3.
By Cancer
Type
6.3.3.
Australia Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug
Type
6.3.3.2.2.
By
Service Type
6.3.3.2.3.
By Cancer
Type
6.3.4.
Japan Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Drug
Type
6.3.4.2.2.
By
Service Type
6.3.4.2.3.
By Cancer
Type
6.3.5.
South Korea Cancer Immunotherapy Drug Discovery
Outsourcing Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Drug
Type
6.3.5.2.2.
By
Service Type
6.3.5.2.3.
By Cancer
Type
7. Europe Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Drug
Type
7.2.2.
By
Service Type
7.2.3.
By Cancer
Type
7.2.4.
By Country
7.3.
Europe: Country Analysis
7.3.1.
France Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug
Type
7.3.1.2.2.
By
Service Type
7.3.1.2.3.
By Cancer
Type
7.3.2.
Germany Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug
Type
7.3.2.2.2.
By
Service Type
7.3.2.2.3.
By Cancer
Type
7.3.3.
Spain Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug
Type
7.3.3.2.2.
By
Service Type
7.3.3.2.3.
By Cancer
Type
7.3.4.
Italy Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug
Type
7.3.4.2.2.
By
Service Type
7.3.4.2.3.
By Cancer
Type
7.3.5.
United Kingdom Cancer Immunotherapy Drug Discovery
Outsourcing Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug
Type
7.3.5.2.2.
By
Service Type
7.3.5.2.3.
By Cancer
Type
8. North America Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Drug
Type
8.2.2.
By
Service Type
8.2.3.
By Cancer
Type
8.2.4.
By Country
8.3.
North America: Country Analysis
8.3.1.
United States Cancer Immunotherapy Drug Discovery
Outsourcing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug
Type
8.3.1.2.2.
By
Service Type
8.3.1.2.3.
By Cancer
Type
8.3.2.
Mexico Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug
Type
8.3.2.2.2.
By
Service Type
8.3.2.2.3.
By Cancer
Type
8.3.3.
Canada Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug
Type
8.3.3.2.2.
By
Service Type
8.3.3.2.3.
By Cancer
Type
9. South America Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Drug
Type
9.2.2.
By
Service Type
9.2.3.
By Cancer
Type
9.2.4.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug
Type
9.3.1.2.2.
By
Service Type
9.3.1.2.3.
By Cancer
Type
9.3.2.
Argentina Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Type
9.3.2.2.2.
By
Service Type
9.3.2.2.3.
By Cancer
Type
9.3.3.
Colombia Cancer Immunotherapy Drug Discovery Outsourcing
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug
Type
9.3.3.2.2.
By
Service Type
9.3.3.2.3.
By Cancer
Type
10. Middle East and Africa
Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Service Type
10.2.3. By Cancer Type
10.2.4. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Drug
Type
10.3.1.2.2.
By
Service Type
10.3.1.2.3.
By Cancer
Type
10.3.2. Saudi Arabia Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Drug
Type
10.3.2.2.2.
By
Service Type
10.3.2.2.3.
By Cancer
Type
10.3.3. UAE Cancer
Immunotherapy Drug Discovery Outsourcing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Drug
Type
10.3.3.2.2.
By
Service Type
10.3.3.2.3.
By Cancer
Type
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global Cancer Immunotherapy Drug Discovery Outsourcing
Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15.
PESTLE Analysis
16.
Competitive Landscape
16.1. Covance, Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products &
Services
16.1.4. Financials (In case
of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2.
Horizon Discovery Group PLC
16.3.
Crown Bioscience, Inc.
16.4. Promega Corporation
16.5. HD Biosciences Co., Ltd.
16.6. BPS Bioscience, Inc.
16.7. Genscript Biotech Corporation
16.8. DiscoverX Corporation
16.9. Celentyx Ltd.
16.10. ImmunXperts SA
17. Strategic Recommendations
18. About Us & Disclaimer